基于实验室的广泛耐药结核病监测，中国。
Laboratory-based surveillance of extensively drug-resistant tuberculosis, China.
机构信息
Shandong Provincial Chest Hospital, Jinan, People's Republic of China.
出版信息
Emerg Infect Dis. 2011 Mar;17(3):495-7. doi: 10.3201/eid1703.100812.
Abstract
To estimate the prevalence of extensively drug-resistant tuberculosis (XDR TB) in China, we retrospectively analyzed drug-resistance profiles of 989 clinical Mycobacterium tuberculosis isolates. We found 319 (32.3%) isolates resistant to ≥1 first-line drugs; 107 (10.8%) isolates were multidrug resistant, of which 20 (18.7%) were XDR. XDR TB is of major concern in China.
摘要
为了估计中国广泛耐药结核病（XDR-TB）的流行率，我们回顾性分析了 989 株临床分枝杆菌结核分离株的耐药谱。我们发现 319 株（32.3%）分离株对至少 1 种一线药物耐药；107 株（10.8%）分离株为耐多药，其中 20 株（18.7%）为 XDR。XDR-TB 在中国受到高度关注。
相似文献
1
Laboratory-based surveillance of extensively drug-resistant tuberculosis, China.基于实验室的广泛耐药结核病监测，中国。
Emerg Infect Dis. 2011 Mar;17(3):495-7. doi: 10.3201/eid1703.100812.
2
Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.结核分枝杆菌北京/W 家族临床分离株耐药性与亚家族之间的相关性：2009 - 2013年中国新疆前瞻性研究
Med Sci Monit. 2015 May 7;21:1313-8. doi: 10.12659/MSM.892951.
3
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
4
Extensively drug-resistant tuberculosis, China.广泛耐药结核病，中国。
Emerg Infect Dis. 2011 Mar;17(3):558-60. doi: 10.3201/eid1703.100919.
5
Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.中国山东省基于人群的广泛耐药结核病监测。
Int J Tuberc Lung Dis. 2012 May;16(5):612-4. doi: 10.5588/ijtld.11.0507. Epub 2012 Mar 7.
6
Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.结核分枝杆菌分离株的耐药谱和耐药水平同时增加。
Int J Tuberc Lung Dis. 2010 Nov;14(11):1436-41, i.
7
Drug Resistance Characteristics of Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China.中国结核病患者分离株对 12 种抗结核药物的耐药特征。
Front Cell Infect Microbiol. 2019 Nov 5;9:345. doi: 10.3389/fcimb.2019.00345. eCollection 2019.
8
Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa.南非广泛耐药结核病的耐药性不断增加。
Emerg Infect Dis. 2011 Mar;17(3):510-3. doi: 10.3201/eid1703.101363.
9
Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990-2007.1990-2007 年巴基斯坦结核分枝杆菌耐药趋势。
Int J Infect Dis. 2009 Nov;13(6):e377-82. doi: 10.1016/j.ijid.2009.01.008. Epub 2009 Apr 14.
10
Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.W-北京型和非北京型结核分枝杆菌亚谱系感染的肺结核患者的社会人口学和临床特征比较
Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23.
引用本文的文献
1
Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis.全球耐药结核病患病率：系统评价和荟萃分析。
Infect Dis Poverty. 2023 May 25;12(1):57. doi: 10.1186/s40249-023-01107-x.
2
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.结核分枝杆菌临床分离株 thyA、folC 和 dfrA 突变对对氨基水杨酸药物敏感性试验临界浓度的测定。
Ann Clin Microbiol Antimicrob. 2022 Nov 5;21(1):48. doi: 10.1186/s12941-022-00537-z.
3
Risk Factor for Retreatment Episode on Admission Among TB Patients With Schizophrenia.合并精神分裂症的结核病患者入院时再次治疗的危险因素。
Front Psychiatry. 2021 Dec 9;12:793470. doi: 10.3389/fpsyt.2021.793470. eCollection 2021.
4
Prevalence of Antibiotic-Resistant Pulmonary Tuberculosis in Bangladesh: A Systematic Review and Meta-Analysis.孟加拉国耐抗生素肺结核的患病率：一项系统评价与荟萃分析
Antibiotics (Basel). 2020 Oct 17;9(10):710. doi: 10.3390/antibiotics9100710.
5
Risk factors for tuberculous empyema in pleural tuberculosis patients.结核性脓胸患者发生结核性脓胸的危险因素。
Sci Rep. 2019 Dec 20;9(1):19569. doi: 10.1038/s41598-019-56140-4.
6
Risk Factors for False-Negative Interferon-γ Release Assay Results in Culture-Confirmed Childhood TB.影响培养确诊儿童结核病的干扰素-γ 释放试验假阴性结果的因素。
Am J Trop Med Hyg. 2019 Dec;101(6):1303-1307. doi: 10.4269/ajtmh.18-0684.
7
Prevalence of multidrug-resistant tuberculosis in suspected childhood tuberculosis in Shandong, China: a laboratory-based study.中国山东疑似儿童结核病中耐多药结核病的患病率：一项基于实验室的研究。
J Int Med Res. 2020 Jan;48(1):300060519869715. doi: 10.1177/0300060519869715. Epub 2019 Sep 20.
8
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.中国一家三级甲等结核病医院耐药结核病的患病率、风险及基因特征
Infect Drug Resist. 2019 Aug 7;12:2457-2465. doi: 10.2147/IDR.S209971. eCollection 2019.
9
Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai, China.传播是中国上海治疗结核病患者中耐药的一个显著原因。
Sci Rep. 2017 Aug 9;7(1):7691. doi: 10.1038/s41598-017-08061-3.
10
Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China.中国大连耐多药结核病的患病率及危险因素
J Int Med Res. 2017 Dec;45(6):1779-1786. doi: 10.1177/0300060516687429. Epub 2017 Mar 27.
本文引用的文献
1
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.2002 - 2007年抗结核药物耐药性流行病学：全球抗结核药物耐药性监测项目的最新分析
Lancet. 2009 May 30;373(9678):1861-73. doi: 10.1016/S0140-6736(09)60331-7. Epub 2009 Apr 15.
2
Transmission of MDR and XDR tuberculosis in Shanghai, China.中国上海耐多药和广泛耐药结核病的传播
PLoS One. 2009;4(2):e4370. doi: 10.1371/journal.pone.0004370. Epub 2009 Feb 3.
3
Characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates in China.中国广泛耐药结核分枝杆菌临床分离株的特征分析
J Clin Microbiol. 2008 Dec;46(12):4075-7. doi: 10.1128/JCM.00822-08. Epub 2008 Oct 22.
4
Worldwide emergence of extensively drug-resistant tuberculosis.广泛耐药结核病在全球范围内的出现。
Emerg Infect Dis. 2007 Mar;13(3):380-7. doi: 10.3201/eid1303.061400.
5
XDR tuberculosis--implications for global public health.广泛耐药结核病——对全球公共卫生的影响
N Engl J Med. 2007 Feb 15;356(7):656-9. doi: 10.1056/NEJMp068273.
6
Drug-susceptibility testing in tuberculosis: methods and reliability of results.结核病的药敏试验：方法及结果的可靠性
Eur Respir J. 2005 Mar;25(3):564-9. doi: 10.1183/09031936.05.00111304.
7
Is second-line anti-tuberculosis drug susceptibility testing reliable?二线抗结核药物敏感性检测可靠吗？
Int J Tuberc Lung Dis. 2004 Sep;8(9):1157-8.
Zotero 插件